In a filing, Tandem Diabetes Care Inc revealed its EVP & Chief Operating Officer Kyrillos Jean-Claude acquired Company’s shares for reported $0.19 million on Mar 07 ’25. In the deal valued at $18.12 per share,10,538 shares were bought. As a result of this transaction, Kyrillos Jean-Claude now holds 10,538 shares worth roughly $0.18 million.
Then, BLICKENSTAFF KIM D sold 30,000 shares, generating $941,400 in total proceeds. Upon selling the shares at $31.38, the Director now owns 165,190 shares.
Before that, BLICKENSTAFF KIM D sold 10,000 shares. Tandem Diabetes Care Inc shares valued at $300,000 were divested by the Director at a price of $30.00 per share. As a result of the transaction, BLICKENSTAFF KIM D now holds 195,190 shares, worth roughly $3.32 million.
Mizuho initiated its Tandem Diabetes Care Inc [TNDM] rating to a Neutral in a research note published on April 10, 2025; the price target was $20. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in early March from “an Overweight” to “an Equal-weight”. Citigroup also remained covering TNDM and has decreased its forecast on March 04, 2025 with a “Neutral” recommendation from previously “Buy” rating. Wells Fargo revised its rating on March 03, 2025. It rated TNDM as “an Equal weight” which previously was an “an Overweight”.
Price Performance Review of TNDM
On Monday, Tandem Diabetes Care Inc [NASDAQ:TNDM] saw its stock fall -0.18% to $17.03. Over the last five days, the stock has gained 1.07%. Tandem Diabetes Care Inc shares have fallen nearly -52.72% since the year began. Nevertheless, the stocks have fallen -49.72% over the past one year. While a 52-week high of $53.69 was reached on 01/06/25, a 52-week low of $15.75 was recorded on 04/07/25. SMA at 50 days reached $24.06, while 200 days put it at $34.45.
Levels Of Support And Resistance For TNDM Stock
The 24-hour chart illustrates a support level at 16.38, which if violated will result in even more drops to 15.74. On the upside, there is a resistance level at 17.59. A further resistance level may holdings at 18.16. The Relative Strength Index (RSI) on the 14-day chart is 31.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.96, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 71.87%. Stochastics %K at 26.00% indicates the stock is a holding.
How much short interest is there in Tandem Diabetes Care Inc?
A steep rise in short interest was recorded in Tandem Diabetes Care Inc stocks on 2025-03-31, growing by 0.14 million shares to a total of 7.27 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 7.14 million shares. There was a rise of 1.91%, which implies that there is a positive sentiment for the stock.
